    <SEC-DOCUMENT>0001737287-24-000033-index.html : 20240423
    <SEC-HEADER>0001737287-24-000033.hdr.sgml : 20240423
    <ACCEPTANCE-DATETIME>20240423163234
    ACCESSION NUMBER:		0001737287-24-000033
    CONFORMED SUBMISSION TYPE:	DEFA14A
    PUBLIC DOCUMENT COUNT:		3
    FILED AS OF DATE:		20240423
    DATE AS OF CHANGE:		20240423

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001737287
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				823562771
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		DEFA14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38693
    		FILM NUMBER:		24865263

    	BUSINESS ADDRESS:
    		STREET 1:		210 EAST GRAND AVENUE
    		CITY:			SOUTH SAN FRANCISCO
    		STATE:			CA
    		ZIP:			94080
    		BUSINESS PHONE:		(650) 457-2700

    	MAIL ADDRESS:
    		STREET 1:		210 EAST GRAND AVENUE
    		CITY:			SOUTH SAN FRANCISCO
    		STATE:			CA
    		ZIP:			94080
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEFA14A
    <SEQUENCE>1
    <FILENAME>allo-20240423xdefa14axnoti.htm
    <DESCRIPTION>DEFA14A
    <TEXT>
    Document 1 - file: allo-20240423xdefa14axnoti.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>allogenetherapeuticsinc_vx.jpg
    <TEXT>
    Document 2 - file: allogenetherapeuticsinc_vx.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>allogenetherapeuticsinc_vxa.jpg
    <TEXT>
    Document 3 - file: allogenetherapeuticsinc_vxa.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>